Mirae Asset Global ETFs Holdings
MYGN icon

Mirae Asset Global ETFs Holdings’s Myriad Genetics MYGN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$838K Buy
146,594
+36,108
+33% +$164K ﹤0.01% 1733
2026
Q1 		$496K Buy
110,486
+3,514
+3% +$18.3K ﹤0.01% 1894
2025
Q4 		$658K Buy
106,972
+141
+0.1% +$1.02K ﹤0.01% 1749
2025
Q3 		$772K Sell
106,831
-8,741
-8% -$51.9K ﹤0.01% 1643
2025
Q2 		$613K Sell
115,572
-74,844
-39% -$442K ﹤0.01% 1705
2025
Q1 		$1.69M Sell
190,416
-6,585
-3% -$79.1K ﹤0.01% 1231
2024
Q4 		$2.7M Buy
197,001
+8,073
+4% +$149K 0.01% 973
2024
Q3 		$5.17M Sell
188,928
-24,137
-11% -$653K 0.01% 754
2024
Q2 		$5.21M Buy
+213,065
New +$4.67M 0.01% 733

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MYGN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Myriad Genetics (MYGN) stake by 33% in Q2 2026, buying an estimated $164K and bringing the position to 146,594 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

Mirae Asset Global ETFs Holdings first reported a position in MYGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.21M in Q2 2024. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 146,594 shares of Myriad Genetics worth $838K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 36,108 Myriad Genetics shares in Q2 2026, an estimated $164K.
  • Myriad Genetics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1733 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Myriad Genetics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Myriad Genetics position peaked at $5.21M in Q2 2024.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.